{"abstract":"The Food and Drug Administration (FDA or we) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2022/03/24/2022-06220.html","cfr_references":[],"citation":"87 FR 16743","comment_url":null,"comments_close_on":"2022-04-25","correction_of":null,"corrections":[],"dates":"Submit written comments (including recommendations) on the collection of information by April 25, 2022.","disposition_notes":null,"docket_ids":["Docket No. FDA-2021-N-0371"],"dockets":[{"supporting_documents":[{"title":"Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals","document_id":"FDA-2021-N-0371-0008"},{"title":"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Accelerated Approval Disclosures on Direct-to-\nConsumer Prescription Drug Websites","document_id":"FDA-2021-N-0371-0004"},{"title":"Beaver et al 2018 FDA oncology products RE Agency Information Collection Activities; Proposed Collection; Comment Request; Accelerated Approval Disclosures on Direct-toConsumer Prescription Drug Websites","document_id":"FDA-2021-N-0371-0002"},{"title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Accelerated Approval Disclosures on Direct-toConsumer Prescription Drug Websites","document_id":"FDA-2021-N-0371-0001"}],"agency_name":null,"documents":[{"comment_count":3,"comment_start_date":"2022-03-24","updated_at":"2023-02-28T17:14:52.749-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-2021-N-0371-0004","allow_late_comments":null,"id":"FDA-2021-N-0371-0004","comment_end_date":"2022-04-26","regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":4,"id":"FDA-2021-N-0371","title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites"}],"document_number":"2022-06220","effective_on":null,"end_page":16748,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2022/03/24/2022-06220.xml","html_url":"https://www.federalregister.gov/documents/2022/03/24/2022-06220/agency-information-collection-activities-submission-for-office-of-management-and-budget-review","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2022-06220?publication_date=2022-03-24","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2022-03-24/2022-06220/mods.xml","not_received_for_publication":null,"page_length":6,"page_views":{"count":607,"last_updated":"2026-09-22 20:15:08 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2022-03-24/pdf/2022-06220.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2022-06220.pdf?1648039527","publication_date":"2022-03-24","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2022/03/24/2022-06220.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals","document_id":"FDA-2021-N-0371-0008"},{"title":"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Accelerated Approval Disclosures on Direct-to-\nConsumer Prescription Drug Websites","document_id":"FDA-2021-N-0371-0004"},{"title":"Beaver et al 2018 FDA oncology products RE Agency Information Collection Activities; Proposed Collection; Comment Request; Accelerated Approval Disclosures on Direct-toConsumer Prescription Drug Websites","document_id":"FDA-2021-N-0371-0002"},{"title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Accelerated Approval Disclosures on Direct-toConsumer Prescription Drug Websites","document_id":"FDA-2021-N-0371-0001"}],"comments_count":3,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-2021-N-0371","supporting_documents_count":4,"docket_id":"FDA-2021-N-0371","document_id":"FDA-2021-N-0371-0004","regulation_id_number":null,"title":"Agency Information Collection Activities; Proposed Collection; Comment Request; Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites","checked_regulationsdotgov_at":"2023-02-28T22:14:51Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":16743,"subtype":null,"title":"Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites","toc_doc":"Accelerated Approval Disclosures on Direct-to-Consumer Prescription Drug Websites","toc_subject":"Agency Information Collection Activities; Proposals, Submissions, and Approvals:\n","topics":[],"type":"Notice","volume":87}